JP6497247B2 - Method for producing cross-linked fluororesin powder - Google Patents

Description

  The present invention relates to a method for producing a crosslinked fluororesin powder.

  The demand for powdered cross-linked fluororesin (cross-linked fluororesin powder) is increasing due to its excellent characteristics in applications such as mechanical parts such as sliding bodies.

  As a method for producing such a crosslinked fluororesin powder, an uncrosslinked fluororesin powder is formed into a mat or sheet and then heated to a temperature slightly above the melting point of the fluororesin in a low oxygen atmosphere gas. In such a state, a method is known in which a predetermined amount of radiation is irradiated to cause crosslinking, and then cooled to room temperature, and then the crosslinked fluororesin sheet is pulverized with a pulverizer to obtain a crosslinked fluororesin powder having a predetermined particle size. (For example, refer to Patent Document 1).

JP 2002-321216 A

  However, since the cross-linked fluororesin has a high tenacity, it is difficult to pulverize by the conventional method, and it is particularly difficult to finely pulverize.

  On the other hand, with the diversification of applications of the cross-linked fluororesin powder, a cross-linked fluororesin powder having a finer particle size (for example, an average particle size of 20 μm or less) is required.

  Accordingly, an object of the present invention is to provide a method for producing a crosslinked fluororesin powder capable of obtaining a crosslinked fluororesin powder having a minute particle size (for example, an average particle size of 20 μm or less).

  In order to achieve the above object, the present invention provides the following method for producing a crosslinked fluororesin powder.

[1] A mixed powder obtained by mixing a fluororesin powder as a first powder and a second powder that is not fused to the fluororesin powder even under a crosslinking treatment condition of the fluororesin powder. Then, the step of cross-linking the mixed powder is carried out, and the fluororesin powder is obtained by subjecting the cross-linked fluororesin powder to a brittleness treatment followed by a pulverization treatment. Production method.
[2] The method for producing a crosslinked fluororesin powder according to [1], wherein the fluororesin powder has a heat of crystallization of 40 to 50 J / g.
[3] The crosslinked fluororesin powder according to [1] or [2], further including a step of separating the first powder and the second powder after the step of performing the crosslinking treatment. Manufacturing method.
[4] The method for producing a crosslinked fluororesin powder according to any one of [1] to [3], wherein the second powder has a property of being dissolved in an inorganic solvent and / or an organic solvent.
[5] The method for producing a crosslinked fluororesin powder according to any one of [1] to [3], wherein the second powder is a magnetic substance.
[6] The crosslinked fluorine according to any one of [1] to [3], wherein the second powder has a specific gravity of not less than twice or not more than 1/2 of the specific gravity of the first powder. Manufacturing method of resin powder.
[7] The second powder has an average particle size smaller than the average particle size of the first powder, and a mixing ratio (volume ratio) of the second powder to the first powder. ) Is the method for producing a crosslinked fluororesin powder according to any one of [1] to [6], wherein (the second powder / the first powder) = 2 or more.
[8] The second powder has an average particle size larger than the average particle size of the first powder, and a mixing ratio (volume ratio) of the second powder to the first powder. ) Is the method for producing a crosslinked fluororesin powder according to any one of [1] to [6], wherein (the second powder / the first powder) = 2 or more.
[9] The method for producing a crosslinked fluororesin powder according to any one of [1] to [8], wherein the mixed powder is formed into a tablet shape before the crosslinking treatment.
[10] The method for producing a crosslinked fluororesin powder according to any one of [1] to [9], wherein the fluororesin powder is a powder having an average particle size of 10 μm or less.

  ADVANTAGE OF THE INVENTION According to this invention, the manufacturing method of the crosslinked fluororesin powder which can obtain the crosslinked fluororesin powder of a micro particle size (for example, average particle diameter of 20 micrometers or less) can be provided.

It is the schematic which shows the mixing process and shaping | molding process in the manufacturing method of the crosslinked fluororesin powder which concerns on embodiment of this invention. It is the schematic which shows the crosslinking process process in the manufacturing method of the crosslinked fluororesin powder which concerns on embodiment of this invention. It is the schematic which shows the isolation | separation process in the manufacturing method of the crosslinked fluororesin powder which concerns on embodiment of this invention. It is a graph which shows the test result for deriving | leading-out the optimal range of crystallization calorie | heat amount about the fluororesin powder after the embrittlement process used for the mixing process of FIG. It is explanatory drawing for calculating the mixing ratio of the 1st powder in the manufacturing method of the crosslinked fluororesin powder concerning an embodiment of the invention, and the 2nd powder, and (a) is the 1st adjoining This is a case where the powder is surrounded by a common second powder, and (b) is a case where the adjacent first powder is surrounded by different second powders.

  Hereinafter, a method for producing a crosslinked fluororesin powder according to an embodiment of the present invention will be described with reference to the drawings.

  FIG. 1 is a schematic view showing a mixing step and a molding step in a method for producing a crosslinked fluororesin powder according to an embodiment of the present invention.

  The method for producing a crosslinked fluororesin powder according to an embodiment of the present invention includes a fluororesin powder 1 as a first powder and the fluororesin powder 1 even under the crosslinking treatment conditions of the fluororesin powder 1. After mixing with the 2nd powder 2 which is not melt | fused, it is set as the mixed powder 3, and the process which bridge | crosslinks with respect to the mixed powder 3 is provided.

(First powder)
The fluororesin powder 1 as the first powder is an uncrosslinked fluororesin powder, and the fluororesin is not particularly limited. For example, polytetrafluoroethylene (PTFE), tetrafluoro An ethylene-perfluoroalkyl vinyl ether copolymer (PFA), a tetrafluoroethylene-hexafluoropropylene copolymer (FEP), or the like can be used. It is desirable to use polytetrafluoroethylene (PTFE). Two or more kinds can be used in combination.

  The fluororesin powder 1 is obtained by carrying out an embrittlement treatment and then performing a pulverization treatment to reduce the particle size.

  As the embrittlement treatment, for example, fluororesin powder (raw material having an average particle size exceeding 20 μm) is irradiated with ionizing radiation such as γ-rays, electron beams, X-rays, neutron rays, and high-energy ions at room temperature and atmospheric pressure. To do. Among these, γ-ray irradiation is desirable. The irradiation dose and the irradiation time are appropriately adjusted in the range of 0.1 kGy to 10 MGy and 1 to 100 hours. It is possible to adjust the irradiation dose and irradiation time so that the heat of crystallization of the fluororesin powder after embrittlement is 40-50 J / g. It is desirable in that it can be compatible with sex. The amount of crystallization heat is measured by a differential scanning calorimeter (DSC) according to JIS K7121. Most preferably, the amount of crystallization heat is adjusted to 40 to 50 J / g.

  An example of the basis for deriving the above preferable range of the amount of crystallization heat is shown in FIG. FIG. 4 is a graph showing test results for deriving the optimum range of crystallization heat amount for the fluororesin powder after embrittlement used in the mixing step of FIG.

  In the graph of FIG. 4, the horizontal axis indicates the heat of crystallization of the PTFE powder subjected to the embrittlement before the cross-linking treatment, the left vertical axis indicates the heat of crystallization of the PTFE powder after the cross-linking treatment, and the right vertical axis. An axis | shaft shows the average particle diameter after the embrittlement process of the PTFE powder before a crosslinking process, and a grinding | pulverization process. However, the plot at 23 J / g on the horizontal axis is a plot for PTFE powder not subjected to embrittlement treatment. The embrittlement treatment was performed by irradiating 10 kGy of γ rays for 1 to 100 hours at room temperature and atmospheric pressure, and the crosslinking treatment was performed at 340 ° C., an oxygen-free atmosphere, and an electron beam dose of 100 kGy. The irradiation time is longer as it goes to the right on the horizontal axis, and the powder becomes more brittle. In the pulverization treatment, PTFE powder was finely pulverized at 2 to 4 kg / hour with a jet mill (trade name: STJ-200, manufactured by Seishin). The amount of crystallization heat was measured by DSC. Even when a fluororesin powder other than the PTFE powder was used, a result showing a tendency similar to that in FIG. 4 was obtained.

  FIG. 4 shows that the crystallization heat amount becomes 40 J / g or more when the average particle size after the pulverization treatment is about 10 μm or less, and the crystallization heat amount becomes about 35 J / g or less after the crosslinking treatment becomes about 35 J / g or less. By carrying out the embrittlement treatment so as to be in the range of X shown, it is possible to best balance both good pulverization properties in the pulverization treatment and excellent wear resistance after the crosslinking treatment. The brittleness is such that the crystallization heat quantity becomes 34 J / g or more at which the average particle size after the pulverization treatment is about 15 μm or less, and the crystallization heat quantity after the cross-linking treatment is about 56 J / g or less at which the crystallization heat quantity is about 40 J / g or less Even when the crystallization treatment is performed, both good pulverization property in the pulverization treatment and excellent wear resistance after the crosslinking treatment can be achieved to some extent. Further, the heat of crystallization is 37 J / g or more so that the average particle size after the pulverization is about 12 μm or less, and the heat of crystallization is 53 J / g or less so that the heat of crystallization after the crosslinking is about 37 J / g or less. Alternatively, embrittlement treatment may be performed.

  The pulverization treatment after the embrittlement treatment can be performed, for example, by impact (jet mill method) or shear (mortar method). The pulverization process is continued until the diameter can no longer be reduced. Since the fluororesin powder is easily pulverized by the embrittlement treatment, the pulverization treatment preferably has an average particle size of 3 to 15 μm, more preferably an average particle size of 3 to 12 μm, and even more preferably an average particle size. Finely pulverized to a particle size of 3-10 μm. The average particle diameter of the obtained fluororesin powder is almost determined by the embrittlement treatment conditions.

  As the fluororesin powder 1, it is desirable to use a powder having a particle size equal to or smaller than a particle size desired to be finally obtained. For example, if a crosslinked fluororesin powder having an average particle size of 20 μm or less is desired, a fluororesin powder having an average particle size of 20 μm or less is used. In the present embodiment, not only an average particle diameter of 20 μm or less, but also a fluororesin powder having an average particle diameter of 15 μm or less, or a fluororesin powder having an average particle diameter of 10 μm or less can be applied. Although a minimum is not specifically limited, For example, the fluororesin powder with an average particle diameter of 1 micrometer or more can be used. Since the average particle size is often somewhat larger after the crosslinking treatment, it is desirable to use, as a raw material, a fluororesin powder having an average particle size smaller than the average particle size desired to be finally obtained. In the present embodiment, the average particle diameter means a particle diameter at a point where the cumulative distribution of particle diameters is 50%.

(Second powder)
The second powder 2 has a characteristic of not being fused to the fluororesin powder 1 even under the crosslinking treatment conditions of the fluororesin powder 1. Thereby, it becomes possible to easily separate the fluororesin powder 1 and the second powder 2 in the separation step described later. Specifically, it has heat resistance that is stable even at a crosslinking temperature and not fused to the fluororesin powder 1, and radiation resistance that is stable even under radiation during crosslinking and does not fuse and crosslink to the fluororesin powder 1.

  Since the second powder 2 is present during the crosslinking treatment, it is possible to prevent the particles of the fluororesin powder 1 from being fused or cross-linked, so that the average particle size of the cross-linked cross-linked fluororesin powder 1A is large. Can be suppressed.

  As the second powder 2, for example, a powder having a property of being dissolved in an inorganic solvent and / or an organic solvent, a magnetic powder, and a specific gravity of not less than twice or less than ½ of the specific gravity of the first powder 1. A powder having is preferred.

  Examples of the powder having the property of being dissolved in an inorganic solvent and / or an organic solvent include, for example, salt particles (hereinafter referred to as salts) that dissolve in water, alcohol, etc., silica that dissolves in sodium sulfate, hydrofluoric acid, and the like Powder is preferred.

  As the magnetic powder (ferromagnetic powder), for example, ferrite powder and iron powder are suitable.

  As the powder having a specific gravity of not less than twice or not more than 1/2 of the specific gravity of the first powder 1, for example, iron powder and salt are suitable.

(Mixing process)
In the method for producing a crosslinked fluororesin powder according to an embodiment of the present invention, first, as shown in FIG. 1 (left figure, center figure), fluororesin powder 1 as a first powder, The second powder 2 is mixed to obtain a mixed powder 3.

  As a mixed state, it is desirable that the second powder 2 surrounds the individual particles of the fluororesin powder 1 so that the particles of the fluororesin powder 1 are not in contact with each other as much as possible.

  Therefore, when the second powder 2 has an average particle size smaller than the average particle size of the first powder 1, the mixing ratio (volume) of the second powder 2 to the first powder 1. The ratio is preferably (second powder / first powder) = 2 or more, more preferably 4 or more. On the other hand, when the second powder 2 has an average particle size larger than the average particle size of the first powder 1, the mixing ratio (volume ratio) of the second powder 2 to the first powder 1 is determined. ) Is preferably (second powder / first powder) = 2 or more, more preferably 8 or more.

  For example, a case where PTFE powder having an average particle diameter of 3 μm is used as the first powder 1 and a salt having an average particle diameter of 1 μm is used as the second powder 2 will be described with reference to FIG.

  FIG. 5 is an explanatory diagram for calculating the mixing ratio of the first powder and the second powder in the method for producing a crosslinked fluororesin powder according to the embodiment of the present invention. The dotted quadrilateral in the figure represents one unit of the mixed powder.

  FIG. 5A shows a case in which adjacent first powders are surrounded by a common second powder. In this case, considering the cubic filling model, the volume ratio is as follows. Of powder = 1: 3.6. Therefore, in order to obtain an ideal form in which the entire circumference of each first powder is surrounded by the second powder, the second powder is 3.6 times or more (volume ratio) of the first powder 1. Mix so that

  FIG. 5B shows a case where adjacent first powders are surrounded by separate second powders. In this case, considering a cubic filling model, the volume ratio is as follows. Powder = 1: 8. Therefore, in order to obtain an ideal form in which the entire circumference of each individual first powder is surrounded by the second powder, the second powder is 8 times or more (volume ratio) of the first powder 1. Mix like so.

  In the case of the embodiment shown in FIG. 5 (b), the proportion of the fluororesin powder particles 1 fused and cross-linked at the time of cross-linking can be reduced compared to the case of the embodiment shown in FIG. 5 (a). When it is desired to obtain a cross-linked fluororesin powder having an average particle diameter close to the average particle diameter of the raw material used, the second powder is mixed so as to be 8 times or more (volume ratio) of the first powder 1. good. On the other hand, when giving priority to production efficiency, the second powder may be mixed so as to be about 3 to 4 times (volume ratio) of the first powder 1.

(Molding process)
Subsequently, as shown in FIG. 1 (right figure), it is preferable to use the tableting machine 10 to form the mixed powder 3 into a tablet before the crosslinking treatment is performed. By using the tablet-like mixed powder 3A, the handling of the powder becomes simple and can be continuously put into the crosslinking apparatus, so that the productivity is improved. The molding method is not particularly limited. A granulator or the like may be used.

  The tablet form in the present embodiment includes not only the tablet form (columnar, disk-like, rugby ball-like) often found in pharmaceutical products, but also a troche-like (ring-like) with a hole in the center of the tablet or a prismatic shape. Is also included. When irradiating from the top, if the thickness is too large, it takes time for the crosslinking treatment, so it is preferable to set the thickness (height) to about 1 mm or less.

(Crosslinking process)
Thereafter, the mixed powder 3 is subjected to a crosslinking treatment using, for example, a crosslinking apparatus as shown in FIG.

  FIG. 2 is a schematic view showing a crosslinking treatment step in the method for producing a crosslinked fluororesin powder according to the embodiment of the present invention.

  The tablet-like mixed powder 3 </ b> A is successively carried into the work container 13 having the electron beam irradiation device 12 by the belt conveyor 11, irradiated with the electron beam, and then carried out of the work container 13 by the belt conveyor 11. The Thereby, tablet-like crosslinked mixed powder 3B is obtained.

  As a crosslinking treatment condition, an ionizing radiation is irradiated in an irradiation dose range of 0.1 kGy to 10 MGy in an oxygen-free atmosphere or a low-oxygen atmosphere of about 500 ppm or less while being heated above the melting point of the fluororesin powder 1. Is desirable. As ionizing radiation, γ-rays, electron beams, X-rays, neutron beams, high-energy ions and the like can be used, but electron beams are preferable.

  For example, when PTFE is used as the fluororesin, it is desirable to irradiate ionizing radiation while the fluororesin powder 1 is heated to a temperature higher than 327 ° C. which is the crystal melting point of this material. Moreover, when using PFA and FEP, it is desirable to irradiate with radiation by heating to a temperature higher than the crystal melting point specified by 300 to 315 ° C. for the former and 260 to 275 ° C. for the latter. However, excessive heating leads to the cleavage and decomposition of the molecular main chain, so the heating temperature should be kept within a range of 10 to 30 ° C. higher than the crystalline melting point of the fluororesin.

(Separation process)
After the cross-linking treatment step, a cross-linked fluororesin powder 1A is obtained through a step of separating the first powder 1 and the second powder 2.

  FIG. 3 is a schematic view showing a separation step in the method for producing a crosslinked fluororesin powder according to an embodiment of the present invention, and has the property of being dissolved in an inorganic solvent and / or an organic solvent as the second powder 2. An embodiment in the case of using a powder (for example, a salt or sodium sulfate) is shown. For ease of understanding, only one tablet-like crosslinked mixed powder 3B is shown in an enlarged manner.

  When the tablet-like cross-linked mixed powder 3B is put into a container 21 containing water 20, the second powder 2 is gradually dissolved in water (upper view and central view in FIG. 3). Next, when this aqueous solution is filtered through the filter 22, the second powder 2 is dissolved in the aqueous solution, so that it passes through the filter 22 and is discharged to the container 23. Only the fluororesin powder 1A remains (lower figure in FIG. 3). Finally, by drying the water adhering to the cross-linked fluororesin powder, a cross-linked fluororesin powder 1A having a desired average particle diameter can be obtained (lower diagram in FIG. 3).

  If the fluororesin powder particles are partly fused and cross-linked, resulting in a particle size larger than the desired average particle size, the desired average particle size is obtained by grinding. Cross-linked fluororesin powder 1A can be obtained. In this case, even if some of the particles of the fluororesin powder are fused and crosslinked, the second powder 2 exists as a result of the second powder 2 functioning as a barrier at the time of crosslinking. Since the cross-linked fluororesin powder 1A is more easily pulverized than the case where it is cross-linked without pulverization, it can be pulverized.

  When magnetic powder (for example, ferrite powder) is used as the second powder 2, the second powder 2 can be separated from the tablet-like crosslinked mixed powder 3B by using a magnet or the like, and the crosslinked fluorine. Resin powder 1A can be obtained.

  When a powder having a specific gravity of not less than twice or not more than ½ of the specific gravity of the first powder 1 is used as the second powder 2, a method such as wind separation or vibration separation, or a dry type The second powder 2 can be separated from the tablet-like cross-linked mixed powder 3B using a specific gravity sorter or the like, and the cross-linked fluororesin powder 1A can be obtained.

  If it is not necessary to separate the first powder 1 and the second powder 2, this step can be omitted.

[Effect of the embodiment of the present invention]
According to the embodiment of the present invention, a cross-linked fluororesin powder capable of obtaining a cross-linked fluororesin powder having a fine particle size (average particle size of 20 μm or less, particularly average particle size of 10 μm or less), which has been difficult in the past, has been obtained. The manufacturing method of can be provided. Moreover, according to this Embodiment, it is possible to manufacture the cross-linked fluororesin powder having various particle sizes from a large particle size to a minute particle size.

  According to the embodiment of the present invention (especially when a fluororesin powder having a crystallization heat quantity of 40 to 50 J / g is used), a crosslinked fluororesin powder having a fine particle size and excellent wear resistance is obtained. A method for producing a obtainable crosslinked fluororesin powder can be provided.

  The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto.

  PTFE powder having an average particle size of 3.4 μm as the first powder 1 (trade name: TFW-3000F, manufactured by Seishin Enterprise Co., Ltd.) (Reference Examples 1, 2 and Comparative Example 1), and crystallization calorie 45 J / g, Using a PTFE powder (Example 1) having an average particle diameter of 6.5 μm and using a salt having an average particle diameter of 1 μm as the second powder 2, the crosslinked fluororesin powder according to the embodiment of the present invention. Manufactured. The PTFE powder of Example 1 was irradiated with γ rays at 100 kGy for 10 hours on a PTFE powder having an average particle size of 25 μm (trade name: TFW-500, manufactured by Seishin Enterprise Co., Ltd.), and then applied to a jet mill. And obtained by pulverization. The salt used was a product obtained by pulverizing commercially available salt (manufactured by Salt Business Center) to 1 μm by a dry pulverization method (a hammer mill was used but a jet mill or the like may be used).

  In Reference Example 1, PTFE powder was used so that the mixing ratio (volume ratio) of the first powder 1 (PTFE powder) and the second powder 2 (salt) was the former: the latter = 1: 3.6. 1 part by mass of the body and 1.8 parts by mass of salt were mixed to obtain a mixed powder, which was formed into a tablet and then subjected to crosslinking treatment (340 ° C., oxygen-free atmosphere, electron beam irradiation dose of 100 kGy).

  In Reference Example 2, the PTFE powder 1 so that the mixing ratio (volume ratio) of the first powder 1 (PTFE powder) and the second powder 2 (salt) is the former: the latter = 1: 8. Mass parts and 4 parts by mass of salt were mixed to form a mixed powder, formed into a tablet, and then subjected to crosslinking treatment (340 ° C., oxygen-free atmosphere, electron beam irradiation dose of 100 kGy).

  In Example 1, the PTFE powder 1 was used so that the mixing ratio (volume ratio) of the first powder 1 (PTFE powder) and the second powder 2 (salt) was the former: the latter = 1: 12. Mass parts and 6 parts by mass of salt were mixed to obtain a mixed powder, which was formed into a tablet shape and then subjected to crosslinking treatment (340 ° C., oxygen-free atmosphere, electron beam irradiation dose 100 kGy).

  After cross-linking, the tablet-like mixed powder is put into alcohol, the second powder 2 (salt) is dissolved in alcohol, and the cross-linked fluoro resin powder is dispersed in the alcohol solution. The particle size distribution was measured by SEISHIN LMS-30. It measured similarly about the raw material PTFE powder. The results are shown in Tables 1-2. In Tables 1 and 2, D (10%) is the particle diameter at a point where the cumulative distribution of particle diameters is 10%, and D (50%) is the particle diameter at which the particle diameter is 50% (average particle diameter). (Diameter) and D (90%) indicate the particle diameter at the point where the cumulative distribution of particle diameters is 90%.

  Without mixing the second powder, only the first powder 1 (PTFE powder) was formed into a tablet and then subjected to crosslinking treatment (340 ° C., oxygen-free atmosphere, electron beam irradiation dose 100 kGy). In Comparative Example 1, since the first powders are fused and integrated, no powder can be obtained. An example of pulverizing the integrated melt is shown in Table 3.

  As can be seen from Tables 1 to 3, in Reference Examples 1 and 2 and Example 1, a crosslinked fluororesin powder having a fine particle size (average particle size of 20 μm or less) was obtained. Despite the use of the same PTFE powder, a crosslinked fluororesin powder having an average particle size exceeding 20 μm was obtained. Moreover, it was difficult for the cross-linked fluororesin powder of Comparative Example 1 to be finely pulverized to a smaller particle size as compared with the cross-linked fluororesin powders of Reference Examples and Examples.

  In addition, this invention is not limited to the said embodiment and Example, A various deformation | transformation implementation is possible.

1: 1st powder (fluororesin powder), 1A: crosslinked fluororesin powder 2: second powder, 3: mixed powder 3A: mixed powder in tablet form, 3B: crosslinked mixed in tablet form Powder 10: Tableting machine 11: Belt conveyor, 12: Electron beam irradiation device, 13: Work container 20: Water, 20A: Aqueous solution, 21, 23: Container, 22: Filter

Claims (10)

After mixing the fluororesin powder as the first powder with the second powder that is not fused to the fluororesin powder even under the cross-linking conditions of the fluororesin powder, a mixed powder is obtained. And a step of performing a crosslinking treatment on the mixed powder,
The said fluororesin powder is a manufacturing method of the crosslinked fluororesin powder which is obtained by irradiating ionizing radiation at normal temperature and atmospheric pressure , and then pulverizing.   The method for producing a crosslinked fluororesin powder according to claim 1, wherein the fluororesin powder has a crystallization heat amount of 40 to 50 J / g.   The method for producing a crosslinked fluororesin powder according to claim 1 or 2, further comprising a step of separating the first powder and the second powder after the step of performing the crosslinking treatment.   The method for producing a crosslinked fluororesin powder according to any one of claims 1 to 3, wherein the second powder has a property of being dissolved in an inorganic solvent and / or an organic solvent.   The method for producing a crosslinked fluororesin powder according to any one of claims 1 to 3, wherein the second powder is a magnetic substance.   The method for producing a crosslinked fluororesin powder according to any one of claims 1 to 3, wherein the second powder has a specific gravity of not less than twice or not more than 1/2 of the specific gravity of the first powder. .   The second powder has an average particle size smaller than the average particle size of the first powder, and the mixing ratio (volume ratio) of the second powder to the first powder is: (The second powder / the first powder) = 2 or more. The method for producing a crosslinked fluororesin powder according to any one of claims 1 to 6.   The second powder has an average particle size larger than the average particle size of the first powder, and the mixing ratio (volume ratio) of the second powder to the first powder is: (The second powder / the first powder) = 2 or more. The method for producing a crosslinked fluororesin powder according to any one of claims 1 to 6.   The method for producing a crosslinked fluororesin powder according to any one of claims 1 to 8, wherein the mixed powder is formed into a tablet shape before the crosslinking treatment.   The method for producing a crosslinked fluororesin powder according to claim 1, wherein the fluororesin powder is a powder having an average particle size of 10 μm or less.